# L_2022246EN.01007301.xml

| 22.9.2022 | EN | Official Journal of the European Union | L 246/73 |
| --- | --- | --- | --- |

22.9.2022

EN

Official Journal of the European Union

L 246/73

---

DECISION OF THE EEA JOINT COMMITTEE No 127/2022

of 29 April 2022

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/1571]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Regulation (EU) 2021/1379 of 19 August 2021 concerning the non-renewal of approval of the active substance famoxadone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Regulation (EU) 2021/1379 of 19 August 2021 concerning the non-renewal of approval of the active substance famoxadone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.

| (2) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

| 1. | The following indent is added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






  ‘— | 32021 R 1379: Commission Implementing Regulation (EU) 2021/1379 of 19 August 2021 (OJ L 297, 20.8.2021, p. 32).’ |
| --- | --- | --- |

1.

The following indent is added in point 13a (Commission Implementing Regulation (EU) No 540/2011):

‘—

32021 R 1379: Commission Implementing Regulation (EU) 2021/1379 of 19 August 2021 (OJ L 297, 20.8.2021, p. 32).’

| 2. | The following point is inserted after point 13zzzzzzzzzzzzb (Commission Implementing Regulation (EU) 2021/1448):






  ‘13zzzzzzzzzzzzc. | 32021 R 1379: Commission Implementing Regulation (EU) 2021/1379 of 19 August 2021 concerning the non-renewal of approval of the active substance famoxadone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 297, 20.8.2021, p. 32).’ |
| --- | --- | --- |

2.

The following point is inserted after point 13zzzzzzzzzzzzb (Commission Implementing Regulation (EU) 2021/1448):

‘13zzzzzzzzzzzzc.

32021 R 1379: Commission Implementing Regulation (EU) 2021/1379 of 19 August 2021 concerning the non-renewal of approval of the active substance famoxadone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 297, 20.8.2021, p. 32).’

Article 2

The text of Implementing Regulation (EU) 2021/1379 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 30 April 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 29 April 2022.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

---

(1)  
  OJ L 297, 20.8.2021, p. 32.

1

(*1)  No constitutional requirements indicated.

*1

---